Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, Euro 0.12 par value per share
-
Shares outstanding
-
62,254,300
-
Total 13F shares
-
42,425,740
-
Share change
-
+1,673,484
-
Total reported value
-
$980,459,437
-
Price per share
-
$23.11
-
Number of holders
-
35
-
Value change
-
+$36,576,974
-
Number of buys
-
17
-
Number of sells
-
16
Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q1 2024
As of 31 Mar 2024,
Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,425,740 shares.
The largest 10 holders included
GENERAL ATLANTIC, L.P., FMR LLC, venBio Partners LLC, Foresite Capital Management IV, LLC, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, Bain Capital Life Sciences Investors, LLC, COMMODORE CAPITAL LP, Cormorant Asset Management, LP, and Novo Holdings A/S.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.